Related Experiment Video
Updated: Jul 3, 2026
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Severity of lipodystrophy is associated with decreased health-related quality of life
Giovanni Guaraldi1, Rita Murri, Gabriella Orlando
1Department of Medicine and Medical Specialties, Infectious Diseases Clinic, University of Modena and Reggio Emilia, Modena, Italy. g.guaraldi@unimo.it
Insights
Lipodystrophy (LD) significantly impacts health-related quality of life (HRQOL) in HIV patients on HAART. Patient-reported LD severity strongly correlates with diminished HRQOL, highlighting the need for both patient and physician assessments.
Area of Science:
- Medical Science
- Public Health
- Clinical Research
Background:
- Lipodystrophy (LD) is a condition with a significant, yet under-documented, impact on patient quality of life.
- Understanding the health-related quality of life (HRQOL) implications for HIV-infected individuals undergoing highly active antiretroviral therapy (HAART) is crucial.
- Existing literature lacks comprehensive data on the relationship between LD and HRQOL in this population.
Purpose of the Study:
- To assess the impact of lipodystrophy (LD) on the health-related quality of life (HRQOL) among HIV-infected patients receiving highly active antiretroviral therapy (HAART).
- To compare the correlation between LD severity, assessed by both patients and physicians, and HRQOL outcomes.
- To identify key predictors of LD severity from both patient and physician perspectives.
Main Methods:
- A cohort of 401 HIV-infected patients on HAART were evaluated for LD using Multicenter AIDS Cohort Study (MACS) criteria.
- LD severity was assessed using three methods: patient evaluation (HOPSpt), physician evaluation (HOPSph), and the Lipodystrophy Case Definition (LDCD).
- Health-related quality of life (HRQOL) was measured using the MOS-HIV Health Survey.
Main Results:
- 26.5% (patient-based) and 30.4% (physician-based) of patients exhibited severe LD, with females experiencing more severe LD.
- HRQOL scores correlated with LD severity when using patient-based assessments (HOPSpt), but showed limited correlation with physician-based scores (HOPSph, LDCD).
- Mental health, gender, BMI, age, and body image satisfaction predicted patient-based LD severity; female gender, age, WHR, limb fat, and body image predicted physician-based LD severity.
Conclusions:
- Health-related quality of life (HRQOL) is strongly associated with lipodystrophy (LD) severity, particularly when assessed from the patient's perspective.
- Physician-based assessments alone may underestimate the impact of LD on HRQOL in HIV-infected individuals on HAART.
- A comprehensive evaluation of LD's impact requires integrating both patient-reported and physician-observed measures for accurate assessment and management.
Abstract:
The impact of lipodystrophy (LD) on quality of life is high, but it has not been demonstrated in literature. The objective of the study was to assess the impact of LD on the health-related quality of life (HRQOL) in HIV-infected people on highly active antiretroviral therapy (HAART). Patients with LD phenotype defined by the Multicenter AIDS Cohort Study (MACS) were included. Three different methods were used to define LD severity: both patient and physician evaluation using the HIV Outpatient Study (HOPS) severity scales and the Lipodystrophy Case Definition (LDCD). The HRQOL was evaluated by MOS-HIV Health Survey. Four hundred one patients on HAART for a mean of 108 +/- 52 months were evaluated for LD at the Metabolic Clinic of Modena and Reggio Emilia University were enrolled from January 2003 to July 2006. According to self-perceived or physician-based HOPS, 106 (26.5%) and 122 (30.4%) patients had severe LD. Females had significantly more severe LD. Few HRQOL scores correlated to LD severity using the physician-based score (both HOPSph and LDCD), while all the HRQOL scores correlated with LD severity when a patient-based score was used (HOPSpt). In multiple linear regression analysis, Mental Health HRQOL score, gender, body mass index, age, body image satisfaction were independent predictors of patient-based (HOPSpt) LD, while none of the HRQOL scores, but female gender, age, waist-to-hip ratio, limb fat, and body image satisfaction were correlated with physician-estimated HOPSph LD severity. HRQOL was strongly correlated with LD severity when a patient-based score was used. For an overall assessment of the impact of LD on HIV-infected people, both patient-based and physician-based measures are required.
Related Concept Videos
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:19Type I Diabetes III: Clinical Manifestations
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...